Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Steerable sheaths for PFA recalled due to safety risk | Novo Nordisk sues rival Eli Lilly | Anesthesia strategies during TAVR
Wednesday, July 22, 2026
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Steerable sheaths for PFA recalled due to safety risk

More than 750,000 devices are included in the new Class II recall. At this time, however, no devices need to be returned to the manufacturer. 

READ MORE >
FDA recall medical device recall product recall
Share on Twitter Share on Facebook Share on Linkedin

Steerable sheaths for PFA recalled due to safety risk

Share on Twitter Share on Facebook Share on Linkedin
FDA recall medical device recall product recall
More than 750,000 devices are included in the new Class II recall. At this time, however, no devices need to be returned to the manufacturer. 
READ MORE >

Novo Nordisk sues GLP-1 rival Eli Lilly over claims of false advertising

Novo Nordisk filed a lawsuit claiming Eli Lilly ran “false and materially misleading” advertisements that ignore recent data. According to Lilly, though, its message is "truthful" and "grounded in the most direct scientific evidence available."

READ MORE >
A gavel and a stethoscope
Share on Twitter Share on Facebook Share on Linkedin

Novo Nordisk sues GLP-1 rival Eli Lilly over claims of false advertising

Share on Twitter Share on Facebook Share on Linkedin
A gavel and a stethoscope
Novo Nordisk filed a lawsuit claiming Eli Lilly ran “false and materially misleading” advertisements that ignore recent data. According to Lilly, though, its message is "truthful" and "grounded in the most direct scientific evidence available."
READ MORE >

Less invasive anesthesia strategies during TAVR linked to a key benefit

Long-term TAVR outcomes were comparable. When tracking 30-day data, however, researchers found that hospital readmission was much less common for patients treated with regional anesthesia or moderate sedation.

READ MORE >
cardiologists heart doctors
Share on Twitter Share on Facebook Share on Linkedin

Less invasive anesthesia strategies during TAVR linked to a key benefit

Share on Twitter Share on Facebook Share on Linkedin
cardiologists heart doctors
Long-term TAVR outcomes were comparable. When tracking 30-day data, however, researchers found that hospital readmission was much less common for patients treated with regional anesthesia or moderate sedation.
READ MORE >

Featured Articles

More than half of U.S. adults now eligible for statin therapy under new cholesterol guidelines

Thanks to updated guidelines published in March, an additional 21.5 million adults between the ages of 30 and 79 are now eligible for statins. Researchers did emphasize that lifestyle changes are another effective way to reduce ASCVD risk. 

READ MORE >
Continuous and high-adherent statin users had lower baseline arterial stiffness which also grew more slowly over time, a new JAMA Network Open study finds.
Share on Twitter Share on Facebook Share on Linkedin

More than half of U.S. adults now eligible for statin therapy under new cholesterol guidelines

Share on Twitter Share on Facebook Share on Linkedin
Continuous and high-adherent statin users had lower baseline arterial stiffness which also grew more slowly over time, a new JAMA Network Open study finds.
Thanks to updated guidelines published in March, an additional 21.5 million adults between the ages of 30 and 79 are now eligible for statins. Researchers did emphasize that lifestyle changes are another effective way to reduce ASCVD risk. 
READ MORE >

FDA shares warning about certain IV administration sets—heart patients face greatest risk

In most cases, the issue should not cause harm. However, patients with a patent foramen ovale or other right-to-left shunts may face an increased risk of a heart attack or stroke.

READ MORE >
warning safety alert recall healthcare issue
Share on Twitter Share on Facebook Share on Linkedin

FDA shares warning about certain IV administration sets—heart patients face greatest risk

Share on Twitter Share on Facebook Share on Linkedin
warning safety alert recall healthcare issue
In most cases, the issue should not cause harm. However, patients with a patent foramen ovale or other right-to-left shunts may face an increased risk of a heart attack or stroke.
READ MORE >

Heartflow launches new AI-powered staging tool for coronary plaque assessments

In addition to launching Heartflow Plaque Staging, the company also shared new data at SCCT2026 highlighting the importance of using total plaque volume assessments to diagnose and manage heart patients. 

READ MORE >
Heartflow's Plaque Analysis AI-driven software that automtically assesses the coronary arteries, maps them and adds markers for areas of interest with plaque.
Share on Twitter Share on Facebook Share on Linkedin

Heartflow launches new AI-powered staging tool for coronary plaque assessments

Share on Twitter Share on Facebook Share on Linkedin
Heartflow's Plaque Analysis AI-driven software that automtically assesses the coronary arteries, maps them and adds markers for areas of interest with plaque.
In addition to launching Heartflow Plaque Staging, the company also shared new data at SCCT2026 highlighting the importance of using total plaque volume assessments to diagnose and manage heart patients. 
READ MORE >

How much coffee is safe for the heart? Doctors explore the benefits and risks of caffeine

Drinking multiple cups of coffee each day may decrease a person's risk of heart disease, heart failure and stroke. However, too much caffeine can still cause issues.

READ MORE >
old elderly couple coffee drink retired love romance man
Share on Twitter Share on Facebook Share on Linkedin

How much coffee is safe for the heart? Doctors explore the benefits and risks of caffeine

Share on Twitter Share on Facebook Share on Linkedin
old elderly couple coffee drink retired love romance man
Drinking multiple cups of coffee each day may decrease a person's risk of heart disease, heart failure and stroke. However, too much caffeine can still cause issues.
READ MORE >

In Case You Missed It

Parents charged with murder after 7-year-old son died of heart disease at 255 pounds

The young boy was allegedly living on a diet of potato chips and other unhealthy snacks. One prosecutor described the case as "extraordinary, terrible neglect."  

READ MORE >
handcuffs arrested arrest jail
Share on Twitter Share on Facebook Share on Linkedin

Parents charged with murder after 7-year-old son died of heart disease at 255 pounds

Share on Twitter Share on Facebook Share on Linkedin
handcuffs arrested arrest jail
The young boy was allegedly living on a diet of potato chips and other unhealthy snacks. One prosecutor described the case as "extraordinary, terrible neglect."  
READ MORE >

FDA approves surgical device for high-risk aortic procedures

The AMDS Hybrid Prosthesis was designed to help clinicians treat DeBakey Type 1 dissections complicated by malperfusion. It works as a complement to hemiarch replacement, preserving the native arch and making reinterventions possible if needed. 

READ MORE >
Artivion, an Atlanta-based medical device company, has received a Humanitarian Device Exemption (HDE) from the U.S. Food and Drug Administration (FDA) for its AMDS Hybrid Prosthesis designed to treat DeBakey Type 1 dissections when malperfusion occurs. This HDE ensures select patients can be treated with the device before the FDA makes its final approval decision.
Share on Twitter Share on Facebook Share on Linkedin

FDA approves surgical device for high-risk aortic procedures

Share on Twitter Share on Facebook Share on Linkedin
Artivion, an Atlanta-based medical device company, has received a Humanitarian Device Exemption (HDE) from the U.S. Food and Drug Administration (FDA) for its AMDS Hybrid Prosthesis designed to treat DeBakey Type 1 dissections when malperfusion occurs. This HDE ensures select patients can be treated with the device before the FDA makes its final approval decision.
The AMDS Hybrid Prosthesis was designed to help clinicians treat DeBakey Type 1 dissections complicated by malperfusion. It works as a complement to hemiarch replacement, preserving the native arch and making reinterventions possible if needed. 
READ MORE >

Trump administration warns public about risk of fraudulent testing schemes

Fears about the risk of sudden cardiac arrest are being used to order unnecessary electrocardiogram and echocardiograms for young athletes, according to a new warning from multiple federal agencies. 

READ MORE >
consumer alert cardiovascular testing scam
Share on Twitter Share on Facebook Share on Linkedin

Trump administration warns public about risk of fraudulent testing schemes

Share on Twitter Share on Facebook Share on Linkedin
consumer alert cardiovascular testing scam
Fears about the risk of sudden cardiac arrest are being used to order unnecessary electrocardiogram and echocardiograms for young athletes, according to a new warning from multiple federal agencies. 
READ MORE >

In Other News

Judge tosses UnitedHealth’s defamation lawsuit against the Guardian

All six counts of the company’s complaint were dismissed. The lawsuit stems from a May 2025 report from the outlet, where it was alleged the insurer paid incentive payments to nursing homes to reduce hospital transfers.

READ MORE >
court judge ruling case lawsuit dismissal gavel
Share on Twitter Share on Facebook Share on Linkedin

Judge tosses UnitedHealth’s defamation lawsuit against the Guardian

Share on Twitter Share on Facebook Share on Linkedin
court judge ruling case lawsuit dismissal gavel
All six counts of the company’s complaint were dismissed. The lawsuit stems from a May 2025 report from the outlet, where it was alleged the insurer paid incentive payments to nursing homes to reduce hospital transfers.
READ MORE >

FDA issues recall of portable imaging systems

A notice from the agency indicates that systems that have had column replacements might not function appropriately afterward and could pose patient harm.

READ MORE >
warning safety alert recall healthcare issue
Share on Twitter Share on Facebook Share on Linkedin

FDA issues recall of portable imaging systems

Share on Twitter Share on Facebook Share on Linkedin
warning safety alert recall healthcare issue
A notice from the agency indicates that systems that have had column replacements might not function appropriately afterward and could pose patient harm.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup